デフォルト表紙
市場調査レポート
商品コード
1417566

シスタチンC測定市場レポート:2030年までの動向、予測、競合分析

Cystatin C Assay Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

シスタチンC測定市場レポート:2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

シスタチンC測定の動向と予測

世界のシスタチンC測定市場は、2024年から2030年までのCAGRが7.6%で、2030年までに推定5億米ドルに達すると予想されます。この市場の主な促進要因は、腎疾患の有病率の増加とPOC検査の採用拡大です。世界のシスタチンC測定市場の将来は、酵素免疫測定法(ELISA)、粒子増強比濁免疫測定法(PETIA)、粒子増強ネフェロメトリック免疫測定法(PENIA)の各市場における機会によって有望視されています。

シスタチンC測定市場洞察

Lucintelの予測では、臨床診断や研究のための高スループットで高精度な分析装置に対する需要の高まりにより、分析装置が予測期間中に最も高い成長を遂げる見込みです。

この市場において、酵素免疫測定法(ELISA)は、腎機能のモニタリングや診断への応用が拡大しているため、引き続き最大セグメントとなります。

北米は、慢性腎臓病の増加、高齢化人口の増加、同地域におけるヘルスケア支出の増加により、予測期間中に最も高い成長が見込まれています。

よくある質問

Q1.市場規模は?

A1.世界のシスタチンC測定市場は、2030年までに推定5億米ドルに達すると予想されています。

Q2.市場の成長予測は?

A2.世界のシスタチンC測定市場は、2024年から2030年にかけてCAGR 7.6%で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は?

A3.この市場の主な促進要因は、腎疾患の有病率の増加とPOC検査の採用拡大です。

Q4.市場の主要セグメントは?

A4.シスタチンC測定市場の将来は、酵素免疫測定法(ELISA)、粒子増強比濁免疫測定法(PETIA)、粒子増強ネフェロメトリック免疫測定法(PENIA)の各市場における機会により有望視されています。

Q5.市場の主要企業は?

A5.シスタチンC測定の主要企業は以下の通りです。

  • Abbott
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Randox Laboratories

Q6.今後、最大となる市場セグメントは?

A6.Lucintelの予測では、臨床診断や研究のための高スループットで高精度な分析装置に対する需要の高まりにより、分析装置が予測期間中に最も高い成長を遂げる見込みです。

Q7.市場において、今後5年間に最大になると予想される地域は?

A7.北米は、慢性腎臓病の増加、高齢化、ヘルスケア支出の増加により、予測期間中に最も高い成長が見込まれます。

Q8.レポートのカスタマイズは可能?

A8.はい、Lucintelは追加費用なしで10%のカスタマイズが可能です。

目次

第1章 エグゼクティブサマリー

第2章 世界のシスタチンC測定市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界のシスタチンC測定市場動向(2018~2023年)および予測(2024~2030年)
  • 製品別の世界のシスタチンC測定市場
    • アナライザー
    • キット
    • 試薬
  • サンプルタイプ別の世界のシスタチンC測定市場
    • 尿
  • 方法別の世界のシスタチンC測定市場
    • 酵素免疫測定法(ELISA)
    • 粒子増強比濁免疫測定法(PETIA)
    • 粒子増強ネフェロメトリック免疫測定法(PENIA)
    • その他
  • アプリケーション別の世界のシスタチンC測定市場
    • 診断
    • 調査

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のシスタチンC測定市場
  • 北米のシスタチンC測定市場
  • 欧州のシスタチンC測定市場
  • アジア太平洋のシスタチンC測定市場
  • その他地域のシスタチンC測定市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界のシスタチンC測定市場の成長機会
    • サンプルタイプ別の世界のシスタチンC測定市場の成長機会
    • 方法別の世界のシスタチンC測定市場の成長機会
    • アプリケーション別の世界のシスタチンC測定市場の成長機会
    • 地域別の世界のシスタチンC測定市場の成長機会
  • 世界のシスタチンC測定市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のシスタチンC測定市場の能力拡大
    • 世界のシスタチンC測定市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Abbott
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Randox Laboratories
目次

Cystatin C Assay Trends and Forecast

The future of the global cystatin C assay market looks promising with opportunities in the enzyme-linked immunosorbent assay (ELISA), particle-enhanced turbidimetric immunoassay (PETIA), and particle-enhanced nephelometric immunoassay (PENIA) markets. The global cystatin c assay market is expected to reach an estimated $0.5 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of kidney diseases and growing adoption of POC testing.

A more than 150-page report is developed to help in your business decisions.

Cystatin C Assay by Segment

The study includes a forecast for the global cystatin c assay by product, sample type, method, application, and region.

Cystatin C Assay Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Analyzers
  • Kits
  • Reagents

Cystatin C Assay Market by Sample Type [Shipment Analysis by Value from 2018 to 2030]:

  • Blood
  • Urine

Cystatin C Assay Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Particle-Enhanced Turbidimetric Immunoassay (PETIA)
  • Particle-Enhanced Nephelometric Immunoassay (PENIA)
  • Others

Cystatin C Assay Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostics
  • Research

Cystatin C Assay Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cystatin C Assay Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cystatin C assay companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cystatin C assay companies profiled in this report include-

  • Abbott
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Randox Laboratories

Cystatin C Assay Market Insights

Lucintel forecasts that analyzer is expected to witness the highest growth over the forecast period due to rising demand for high-throughput and accurate analyzers for clinical diagnosis and research.

Within this market, enzyme-linked immunosorbent assay (ELISA) will remain the largest segment due to its growing application in monitoring and diagnostic of kidney funtion.

North America is expected to witness highest growth over the forecast period due to rise in chronic kidney disease, growing aging population, and increasing healthcare expenditure in the region.

Features of the Global Cystatin C Assay Market

Market Size Estimates: Cystatin C assay market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cystatin C assay market size by various segments, such as by product, sample type, method, application, and region in terms of value ($B).

Regional Analysis: Cystatin C assay market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, sample types, methods, applications, and regions for the cystatin c assay market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cystatin C assay market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cystatin C assay market size?

Answer: The global cystatin C assay market is expected to reach an estimated $0.5 billion by 2030.

Q2. What is the growth forecast for cystatin c assay market?

Answer: The global cystatin C assay market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the cystatin C assay market?

Answer: The major drivers for this market are increasing prevalence of kidney diseases and growing adoption of POC testing.

Q4. What are the major segments for cystatin C assay market?

Answer: The future of the cystatin c assay market looks promising with opportunities in the enzyme-linked immunosorbent assay (ELISA), particle-enhanced turbidimetric immunoassay (PETIA), and particle-enhanced nephelometric immunoassay (PENIA) markets.

Q5. Who are the key cystatin C assay market companies?

Answer: Some of the key cystatin C assay companies are as follows.

  • Abbott
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Randox Laboratories

Q6. Which cystatin C assay market segment will be the largest in future?

Answer: Lucintel forecasts that analyzer is expected to witness the highest growth over the forecast period due to rising demand for high-throughput and accurate analyzers for clinical diagnosis and research.

Q7. In cystatin C assay market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rise in chronic kidney disease, growing aging population, and increasing healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cystatin c assay market by product (analyzers, kits, and reagents), sample type (blood and urine), method (enzyme-linked immunosorbent assay (ELISA), particle-enhanced turbidimetric immunoassay (PETIA), particle-enhanced nephelometric immunoassay (PENIA), and others), application (diagnostics and research), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cystatin C Assay Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cystatin C Assay Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cystatin C Assay Market by Product
    • 3.3.1: Analyzers
    • 3.3.2: Kits
    • 3.3.3: Reagents
  • 3.4: Global Cystatin C Assay Market by Sample Type
    • 3.4.1: Blood
    • 3.4.2: Urine
  • 3.5: Global Cystatin C Assay Market by Method
    • 3.5.1: Enzyme-Linked Immunosorbent Assay (ELISA)
    • 3.5.2: Particle-Enhanced Turbidimetric Immunoassay (PETIA)
    • 3.5.3: Particle-enhanced Nephelometric Immunoassay (PENIA)
    • 3.5.4: Others
  • 3.6: Global Cystatin C Assay Market by Application
    • 3.6.1: Diagnostics
    • 3.6.2: Research

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cystatin C Assay Market by Region
  • 4.2: North American Cystatin C Assay Market
    • 4.2.2: North American Cystatin C Assay Market by Method: Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), and Others
  • 4.3: European Cystatin C Assay Market
    • 4.3.1: European Cystatin C Assay Market by Product: Analyzers, Kits, and Reagents
    • 4.3.2: European Cystatin C Assay Market by Method: Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), and Others
  • 4.4: APAC Cystatin C Assay Market
    • 4.4.1: APAC Cystatin C Assay Market by Product: Analyzers, Kits, and Reagents
    • 4.4.2: APAC Cystatin C Assay Market by Method: Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), and Others
  • 4.5: ROW Cystatin C Assay Market
    • 4.5.1: ROW Cystatin C Assay Market by Product: Analyzers, Kits, and Reagents
    • 4.5.2: ROW Cystatin C Assay Market by Method: Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cystatin C Assay Market by Product
    • 6.1.2: Growth Opportunities for the Global Cystatin C Assay Market by Sample Type
    • 6.1.3: Growth Opportunities for the Global Cystatin C Assay Market by Method
    • 6.1.4: Growth Opportunities for the Global Cystatin C Assay Market by Application
    • 6.1.5: Growth Opportunities for the Global Cystatin C Assay Market by Region
  • 6.2: Emerging Trends in the Global Cystatin C Assay Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cystatin C Assay Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cystatin C Assay Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Roche Diagnostics
  • 7.3: Siemens Healthcare
  • 7.4: Thermo Fisher Scientific
  • 7.5: Randox Laboratories